Seminars in Nephrology
Volume 28, Issue 5 , Pages 457-469 , September 2008

Renal Supportive Therapy for Pediatric Acute Kidney Injury in the Setting of Multiorgan Dysfunction Syndrome/Sepsis

  • Patrick D. Brophy, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Patrick D. Brophy, MD, Associate Professor, Division Director, Pediatric Nephrology, University of Iowa, 200 Hawkins Dr, Iowa City, IA 52242

References 

  1. Symons JM, Picca S. Acute Kidney injury and dialysis in children: illustrative cases. Sem Neph. 2008;28:431–435
  2. Walters S, Porter C, Brophy PD. Dialysis and pediatric acute kidney injury: choice of renal support modality. Pediatr Nephrol. Published online 16 May 2008.
  3. Flynn JT. Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol. 2002;17:61–69
  4. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet. 2000;356:26–30
  5. Goldstein SL, Somers MJ, Baum MA, Symons JM, Brophy PD, Blowey D, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int. 2005;67:653–658
  6. Goldstein SL, Currier H, Graf JM, Cosio CC, Brewer ED, Sachdeva R. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics. 2001;107:1309–1312
  7. Proulx F, Gauthier M, Nadeau D, Lacroix J, Farrell CA. Timing and predictors of death in pediatric patients with multiple organ system failure. Crit Care Med. 1994;6:1025–1031
  8. Cole L, Bellomo R, Silvester W, Reeves JH. A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a “closed” ICU system. Am J Respir Crit Care Med. 2000;162:191–196
  9. Palevsky PM. Clinical review: timing and dose of continuous renal replacement therapy in acute kidney injury. Crit Care. 2007;1:232
  10. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units—causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med. 1996;24:192–198
  11. Ricci Z, Ronco C, D'amico G, et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant. 2006;21:690–696
  12. Benfield MR, Bunchman TE. Management of acute renal failure. In:  Avner ED,  Harmon WE,  Niaudet P editor. Pediatric nephrology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004;p. 1253–1266
  13. Andreoli SP. Acute renal failure in the newborn. Semin Perinatol. 2004;28:112–123
  14. Maxvold NJ, Bunchman TE. Renal failure and renal replacement therapy. Crit Care Clin. 2003;19:563–575
  15. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: 2nd Int Consensus Conf Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–R212
  16. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;7:1028–1035
  17. Palevsky PM. Dialysis modality and dosing strategy in acute renal failure. Semin Dial. 2006;19:165–170
  18. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med. 1999;8:805–813
  19. Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;5:915–919
  20. Karlowicz MG, Adelman RD. Acute renal failure in the neonate. Clin Perinatol. 1992;19:139–158
  21. Mendley SR, Langman CB. Acute renal failure in the pediatric patient. Adv Ren Replace Ther. 1997;4:Suppl 1:93-101
  22. Sehic A, Chesney RW. Acute renal failure: therapy. Pediatr Rev. 1995;16:137–141
  23. Bunchman TE, Smoyer WE, Valentini RP, Kershaw DB, Gregory MJ, Sedman AB. Modality and mortality in pediatric renal replacement therapy [abstract]. J Am Soc Nephrol. 1994;5:436
  24. Arora P, Kher V, Rai PK, Singhal MK, Galati S, Gupta A. Prognosis of acute renal failure in children: a multivariate analysis. Pediatr Nephrol. 1997;11:153–155
  25. Kandoth PW, Agarwal GJ, Dharnidha VR. Acute renal failure in children requiring dialysis therapy. Indian Pediatr. 1994;31:305–309
  26. Wong W, McCall E, Anderson B, Segedin E, Morris M. Acute renal failure in the paediatric intensive care unit. N Z Med J. 1996;109:459–461
  27. Acharya UT, Singla PN, Singh RG, Usha Mishra OP. Outcome of dialysed patients with acute renal failure. Indian Pediatr. 1996;33:387–390
  28. Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol. 2007;2:732–738
  29. Mehta RL, Pascual MT, Soroko S, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547–2553
  30. Foland JA, Fortenberry JD, Warshaw BL, Pettignano R, Merritt RK, Heard ML, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004;32:1771–1776
  31. Gillespie RS, Seidel K, Symons JM. Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol. 2004;19:1394–1399
  32. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. for the International Surviving Sepsis Campaign Guidelines Committee Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327
  33. Parakininkas D, Greenbaum LA. Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr Crit Care Med. 2004;5:269–274
  34. Bunchman TE, Maxvold NJ, Brophy PD. Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis. 2003;42:1248–1252
  35. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M Septic Acute Kidney Injury in Critically Ill Patients. Clinical characteristics and outcomes beginning and ending supportive therapy for the kidney (BEST kidney) investigators. Clin J Am Soc Nephrol. 2007;2:431–439
  36. Ronco C. Recent evolution of renal replacement therapy in the critically ill patient. Crit Care. 2006;1:123
  37. Ronco C, Bonello M, Bordoni V, Ricci Z, D'Intini V, Bellomo R, et al. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif. 2004;22:164–174
  38. Honoré PM, Joannes-Boyau O, Gressens B. Blood and plasma treatments: the rationale of high-volume hemofiltration. Contrib Nephrol. 2007;156:387–395
  39. Sponsel H, Conger JD. Is parenteral nutrition therapy of value in acute renal failure patients?. Am J Kidney Dis. 1995;25:96–102
  40. Ikizler TA, Himmelfarb J. Nutrition in acute renal failure patients. Adv Ren Replace Ther. 1997;54–634 Suppl 1
  41. Riella MC. Nutrition in acute renal failure. Ren Fail. 1997;19:237–252
  42. Summar M. Current strategies for the management of neonatal urea cycle disorders (proceedings of a consensus conference for the management of patients with urea cycle disorders). J Pediatr. 2001;138:S30–S39
  43. Meyer RJ, Flynn JT, Brophy PD, Smoyer WE, Kershaw DB, Custer JR, et al. Hemodialysis followed by continuous hemofiltration for treatment of lithium intoxication in children. Am J Kidney Dis. 2001;5:1044–1047
  44. Blowey DL, McFarland K, Alon U, McGraw-Houchens M, Hellerstein S, Warady BA. Peritoneal dialysis in the neonatal period: outcome data. J Perinatol. 1993;13:59–64
  45. Gong W-K, Tan T-H, Foong P-P, Murugasu B, Yap H-K. Eighteen years experience in pediatric acute dialysis: analysis of predictors of outcome. Pediatr Nephrol. 2001;16:212–215
  46. Alarabi AA, Peterson T, Danielson BG, Wikstrom B. Continuous peritoneal dialysis in children with acute renal failure. Adv Perit Dial. 1994;10:289–293
  47. Kholi HS, Arora P, Kher V, Gupta A, Sharma RK, Bhaumik SK. Daily peritoneal dialysis using a surgically placed Tenckhoff catheter for acute renal failure in children. Ren Fail. 1995;17:51–56
  48. Flynn JT, Kershaw DB, Smoyer WE, Brophy PD, McBryde KD, Bunchman TE. Peritoneal dialysis for management of pediatric acute renal failure. Perit Dial Int. 2001;21:390–394
  49. Anochie IC, Eke FU. Pediatric acute peritoneal dialysis in southern Nigeria. Postgrad Med J. 2006;82:228–230
  50. Bandeira MF, Gama A, Zagury A, Matulevic LC, Mariz LA, Almeida M. Renal replacement therapy (RRT) in acute renal failure (ARF) in critically ill children under 10 kg. Poster/abstract presented at 25th Annual Dialysis Conference, Tampa, FL, February 28-March 2, 2005.
  51. Phadke KD, Dinaker C. The challenges of treating children with renal failure in a developing country. Perit Dialysis Int. 2001;21:s326–s329
  52. Warady BA, Bunchman T. Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol. 2000;15:11–13
  53. Nash MA, Russo JC. Neonatal lactic acidosis and renal failure: the role of peritoneal dialysis. J Pediatr. 1977;91:101–105
  54. Grostein GP, Bluemkrantz MJ, Kopple JD, Moran JK, Coburn JW. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int. 1981;19:564–567
  55. Barletta JF, Barletta GM, Brophy PD, Maxvold NJ, Hackbarth RM, Bunchman TE. Medication errors and patient complications with continuous renal replacement therapy. Pediatr Nephrol. 2006;21:842–845
  56. Gotloib L, Garmizo L, Varak I, Mines M. Reduction of vital capacity due to increased intra-abdominal pressure during peritoneal dialysis. Perit Dial Bull. 1981;1:63–64
  57. Bunchman TE, Meldrum MK, Meliones JE, Sedman AB, Walters MB, Kershaw DB. Pulmonary function variation in ventilator dependent critically ill infants on peritoneal dialysis. Adv Perit Dial. 1992;8:75–78
  58. Blake PG, Breborowicz A, Han DS, Joffe P, Korbet SM, Warady BA. International Society for Peritoneal Dialysis Standards and Education Subcommittee. Recommended peritoneal dialysis curriculum for nephrology trainees. The International Society for Peritoneal Dialysis (ISPD) Standards and Education Subcommittee. Perit Dial Int. 2000;5:497–502
  59. Goldstein SL, Somers MJ, Brophy PD, Bunchman TE, Baum M, Blowey D, et al. The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: design, development and data assessed. Int J Artif Organs. 2004;27:9–14
  60. Goldstein SL, Hackbarth R, Bunchman TE, Blowey D, Brophy PD Prospective Pediatric CRRT Registry Group Houston. Evaluation of the PRISMA M10 circuit in critically ill infants with acute kidney injury: a report from the Prospective Pediatric CRRT Registry Group. Int J Artif Organs. 2006;29:1105–1108
  61. Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant. 2005;20:1416–1421
  62. Bunchman TE, McBryde KD, Mottes TE, Gardner JJ, Maxvold NJ, Brophy PD. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol. 2001;16:1067-7
  63. House AA, Ronco C. Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury. Blood Purif. 2008;1:30–35
  64. Bunchman TE, Donckerwolcke RA. Continuous arteriovenous hemodiafiltration and continuous veno-venous hemodiafiltration in infants and children. Pediatr Nephrol. 1994;8:96–102
  65. Forni LG, Hilton PJ. Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med. 1997;336:1303–1309
  66. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med. 2000;28:1161–1165
  67. Fleming F, Bohn D, Edwards H, Cox P, Geary D, McCrindle BW, et al. Renal replacement therapy after repair of congenital heart disease in children: a comparison of hemofiltration and peritoneal dialysis. J Thorac Cardiovasc Surg. 1995;109:322–331
  68. Clark WR, Mueller BA, Alaka KJ, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol. 1994;4:1413–1420
  69. Swartz RD, Bustami RT, Daley JM, Gillespie BW, Port FK. Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure. Clin Nephrol. 2005;63:335–345
  70. McBryde KD, Bunchman TE, Kudelka TL, Pasko DA, Brophy PD. Hyperosmolar solutions in continuous renal replacement therapy for hyperosmolar acute renal failure: a preliminary report. Pediatr Crit Care Med. 2005;6:220–225
  71. Bunchman TE, Maxvold NJ, Brophy PD. Pediatric convective hemofiltration: normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis. 2003;42:1248–1252
  72. Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, Loc PP, et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med. 2002;347:895–902
  73. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med. 2000;28:3581–3587
  74. Troyanov S, Cardinal J, Geadah D, Parent D, Courteau S, Caron S, et al. Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant. 2003;5:961–966
  75. Flores FX, Brophy PD, Symons JM, Fortenberry JD, Chua AN, Alexander SR, et al. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol. 2008;23:625-30.
  76. Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med. 2002;28:1434–1439
  77. Stegmayr BG, Banga R, Berggren L, Norda R, Rydvall A, Vikerfors T. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med. 2003;31:1730–1736
  78. Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis. 1995;172:296–301
  79. Stegmayr B. Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome. Clin Chem Lab Med. 1999;37:327–332
  80. Mok Q, Butt W. The outcome of children admitted to intensive care with meningococcal septicaemia. Intensive Care Med. 1996;22:259–263
  81. Ataman K, Jehmlich M, Kock S, Neumann S, Leischik M, Filipovic Z, et al. Short-term cardiovascular effects of plasma-pheresis in norepinephrine-refractory septic shock. Intensive Care Med. 2002;28:1164–1167
  82. Barzilay E, Kessler D, Berlot G, Gullo A, Geber D, Ben Zeev I. Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med. 1989;17:634–637
  83. Schmidt J, Mann S, Mohr VD, Lampert R, Firla U, Zirngibl H. Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis. Intensive Care Med. 2000;26:532–537
  84. Peng ZY, Kiss JE, Cortese-Hasset A, Carcillo JA, Nguyen TC, Kellum JA. Plasma filtration on mediators of thrombotic microangiopathy: an in vitro study. Int J Artif Organs. 2007;5:401–406
  85. Nguyen TC, Carcillo JA. Understanding the role of von Willebrand factor and its cleaving protease ADAM TS13 in the pathophysiology of critical illness. Pediatr Crit Care Med. 2007;2:187–189
  86. Nguyen TC, Liu A, Liu L, Ball C, Choi H, May WS, et al. Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis. Haematologica. 2007;1:121–124
  87. Nguyen TC, Carcillo JA. Bench-to-bedside review: thrombocytopenia-associated multiple organ failure—a newly appreciated syndrome in the critically ill. Crit Care. 2006;10:235
  88. Nguyen TC HM, Han YY, Seidberg N, Carcillo JA. Randomized controlled trial of plasma exchange therapy for thrombocytopenia associated multiple organ failure in children [abstract]. Pediatr Res. 2001;49:42A
  89. Bunchman TE, Brophy PD, Somers MJG, Symons JM, Baum M, Fortenberry J, et al. Protein and caloric delivery in pediatric CRRT: a report from the Prospective Pediatric Continuous Renal Replacement Therapy (PPCRRT) Registry Group. J Am Soc Nephrol. 2003;14:258 (abstr).
  90. Bartlett RH, Mault JR, Dechert RE, Palmer J, Swartz RD, Port FK. Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure?. Surgery. 1986;2:400–408
  91. Davies SP, Reaveley DA, Brown EA, Kox WJ. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Crit Care Med. 1991;12:1510–1515
  92. Davenport A, Roberts NB. Amino acid losses during haemofiltration. Blood Purif. 1989;7:192–196
  93. Mokrzycki MH, Kaplan AA. Protein losses in continuous renal replacement therapies. J Am Soc Nephrol. 1996;10:2259–2263
  94. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med. 2000;4:1161–1165
  95. Bellomo R, Tan HK, Bhonagiri S, Gopal I, Seacombe J, Daskalakis M, et al. High protein intake during continuous hemodiafiltration: impact on amino acids and nitrogen balance. Int J Artif Organs. 2002;4:261–268
  96. Scheinkestel CD, Adams F, Mahony L, Bailey M, Davies AR, Nyulasi I, et al. Impact of increasing parenteral protein loads on amino acid levels and balance in critically ill anuric patients on continuous renal replacement therapy. Nutrition. 2003;9:733–740
  97. Payne-James JJ, De Gara CJ, Grimble GK, Bray MJ, Rana SK, Kapadia S, et al. Artificial nutrition support in hospitals in the United Kingdom—1991: second national survey. Clin Nutr. 1992;4:187–192
  98. Wilmore DW. Alterations in protein, carbohydrate, and fat metabolism in injured and septic patients. J Am Coll Nutr. 1983;2:3–13
  99. Georgieff M, Tugtekin IF. Positive role of immune nutrition on metabolism in sepsis and multi-organ failure. Kidney Int Suppl. 1998;64:S80–S83
  100. Pastores SM, Kvetan V, Katz DP. Immunomodulatory effects and therapeutic potential of glutamine in the critically ill surgical patient. Nutrition. 1994;5:385–391
  101. Zappitelli M, Castillo L, Coss-Bu J, Naipaul A, Juarez M, Jefferson J, et al. Continuous veno-venous hemodialysis leads to amino acid, trace element, and folate clearance in critically ill children. J Am Soc Nephrol. 2006;17:767A (abstr).
  102. Berger MM, Shenkin A, Revelly JP, Roberts E, Cayeux MC, Baines M, et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr. 2004;2:410–416
  103. Churchwell MD, Pasko DA, Btaiche IF, Jain JC, Mueller BA. Trace element removal during in vitro and in vivo continuous haemodialysis. Nephrol Dial Transplant. 2007;10:2970–2977

PII: S0270-9295(08)00113-7

doi: 10.1016/j.semnephrol.2008.05.005

Seminars in Nephrology
Volume 28, Issue 5 , Pages 457-469 , September 2008

Article Tools